Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

New antioxidant for atherosclerosis

Oct. 11, 1996

Novel free radical-scavenging and neuroprotective substance isolated by Japanese researchers

Oct. 11, 1996

New hypocholesterolemic agent from Schering-Plough

Oct. 11, 1996

New strategy for reducing doxorubicin toxicity

Oct. 11, 1996

Kanebo reports antitumor agent with a novel mechanism of action

Oct. 11, 1996

MMP inhibitors from Otsuka

Oct. 11, 1996

Merck describes natural inhibitors of Ras farnesylation

Oct. 11, 1996

Nippon Kayaku evaluates novel doxorubicin preparation

Oct. 11, 1996

Antitumor antibiotics from the Kitasato Institute

Oct. 11, 1996

FK-317, a new antitumor antibiotic from Fujisawa

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...